Refine my results

Patenting government funded innovations as a strategy to increase budget for academic vaccine R&D

Songane, Mario

(Working Papers SES ; 509)

Vaccine development is a lengthy, expensive and risky venture, with the research and development (R&D) process costing billions of dollars. The pre-clinical stage of vaccine R&D is largely performed by academic research institutions, then continued by the pharmaceutical industry though licensing agreements, taking the most promising candidates to the clinical testing stage. Governments play a...